Petwealth Launches with $1.7M to Bring AI Diagnostics to Pet Care
- $1.7M in funding raised
- $399 for The Petwealth Pack (at-home health kit)
- $240B global market for preventive pet healthcare (2023)
Experts would likely conclude that Petwealth's AI-driven diagnostics and strategic partnerships position it as a significant innovator in the growing preventive pet healthcare market, addressing a critical gap in proactive wellness monitoring for pets.
Petwealth Launches with $1.7M to Bring AI Diagnostics to Pet Care
MIAMI, FL – April 07, 2026 – A new player has entered the rapidly expanding pet care market, armed with advanced diagnostics, artificial intelligence, and $1.7 million in funding. Miami-based Petwealth officially emerged from stealth today, launching an at-home health platform for dogs and cats that aims to shift the industry from reactive treatment to proactive wellness. The company's debut is bolstered by strategic partnerships with pet care software giant Kennel Connection and telehealth provider Pawp, creating an integrated ecosystem designed to bring clinical-grade health intelligence directly to consumers and businesses.
Founded in 2025, Petwealth is tapping into a profound shift in American households, where spending on pets now exceeds $200 billion annually. This surge reflects the growing “pet humanization” trend, with owners increasingly seeking the same level of sophisticated, preventive healthcare for their animal companions that they expect for themselves. Petwealth's mission is to meet this demand head-on, providing proactive health data before symptoms of illness appear.
“We are not just building a product. We are building the diagnostic infrastructure that the entire pet health industry has been missing,” stated Angelo Palivos, Co-CEO and Co-Founder of Petwealth. “The partnerships we are announcing today are proof that the industry sees it too.”
A New Frontier in Pet Wellness
At the core of Petwealth's offering is its flagship product, The Petwealth Pack. Priced at $399, the at-home kit combines fecal, oral, and respiratory PCR panels to screen for over 100 health markers. The company utilizes polymerase chain reaction (PCR) testing, long considered a gold standard in human and veterinary molecular diagnostics for its accuracy in detecting the genetic material of pathogens. For pet owners seeking more targeted information, individual panels are available for $175 each.
Once a sample is collected and sent to Petwealth’s laboratory, which the company claims can process thousands of tests daily, results are delivered within 24 to 48 hours. These results are not just raw data; they are processed through an AI-powered platform that translates complex biological information into clear, actionable health insights. This approach places Petwealth within a growing but competitive field of at-home pet diagnostics. Companies like Innovative Pet Lab and Affordable Pet Labs have also been making strides in making wellness testing more accessible. However, Petwealth aims to differentiate itself by combining comprehensive PCR screening with AI-driven interpretation and a deeply integrated service network.
The market for preventive pet healthcare is substantial, valued at nearly $240 billion globally in 2023 and projected to grow significantly. By providing tools for early detection, Petwealth hopes to empower owners to address potential health issues like infections, parasites, and oral diseases long before they become critical and costly emergencies.
Forged from Loss, Driven by Experience
The company’s origin story is deeply personal. Co-founder Angelo Palivos was inspired to create Petwealth following the sudden and unexpected passing of his dog, Mochi. The experience left him questioning why proactive, data-driven health monitoring wasn't readily available for pets. A serial entrepreneur with a background in strategic brand growth, Palivos channeled this motivation into building the platform he wished he had for Mochi.
He is joined by co-founder Zoë Barry, a prominent figure in the digital health space who shaped Petwealth’s commercial strategy. Barry's track record includes founding and leading ZappRx, a platform that streamlined access to specialty medications, which was acquired by Allscripts in 2019. Her experience in navigating the complexities of the human healthcare system, combined with Palivos's entrepreneurial drive, provides a formidable foundation for Petwealth’s ambitious goals. Both founders share a history of launching ventures born from personal experiences with healthcare gaps, lending authenticity to their mission.
Building an Integrated Pet Health Ecosystem
Beyond its technology, Petwealth’s go-to-market strategy hinges on creating a seamless, industry-wide network through key alliances. The company announced an exclusive diagnostic partnership with Kennel Connection, a leading pet care management software used by over 5,500 daycares, boarding facilities, groomers, and pet hotels across the United States. This integration embeds clinical-grade PCR screening directly into the operational workflow of businesses where pets congregate, offering a powerful tool for preventing and managing outbreaks of communicable diseases.
“As the Pet Care Industry continues to grow, and more families cherish the lives of their fur babies, I believe it's our job to bring the most innovative and feature rich technology to the industry at large,” said Jeff Brodsly, Owner and CEO of Kennel Connection. “After hearing Petwealth's story and seeing how this innovative Pet Health Technology is already saving pets lives, it was a no brainer for Kennel Connection to partner with Petwealth.”
To ensure pet owners are not left alone to decipher test results, Petwealth has also partnered with the telehealth service Pawp. This integration provides every Petwealth customer with on-demand, 24/7 access to a licensed veterinarian who can help interpret the diagnostic report, explain what the results mean, and advise on next steps. This crucial step closes the loop between data and action, providing immediate professional guidance.
“At Pawp, we believe every pet parent deserves access to a veterinarian when it matters most,” commented Marc Atiyeh, CEO and Co-Founder of Pawp. “Partnering with Petwealth means that the moment a parent receives diagnostic results, they can connect with a licensed vet to understand what those results mean and what to do next. That closes a real gap in pet care.”
This two-pronged partnership strategy positions Petwealth not just as a direct-to-consumer product but as an infrastructure layer for the entire pet care industry. By integrating with both business management software and consumer-facing telehealth, the company is embedding its diagnostic capabilities at multiple touchpoints in a pet’s life, from a stay at a boarding facility to a wellness check at home. This model could set a new standard for how health and safety are managed across the interconnected services that millions of pet owners rely on every day.
📝 This article is still being updated
Are you a relevant expert who could contribute your opinion or insights to this article? We'd love to hear from you. We will give you full credit for your contribution.
Contribute Your Expertise →